|
|
|
|
|
| Thursday, 09 June 2005 | ||
|
EAU 2005 - ABST[628] VOIDED URINARY SPECIMEN-COMPARISON OF A MULTITARGET IN SITU HYBRIDISATION FLUORESCENCE (FISH) ASSAY, NMP22-BLADDERCHEK© AND CONVENTIONAL CYTOLOGY FOR DETECTION OF TRANSITIONAL CELL CANCER OF THE BLADDER Akkad T.1, Verdorfer I.2, Mueller T.1, Gozzi C.1, Bartsch G.1, Steiner H.1 1Medical University Innsbruck, Urology, Innsbruck, Austria, 2Medical University Innsbruck, Pathology, Innsbruck, Austria INTRODUCTION & OBJECTIVES: To evaluate the multitarget fluorescence in situ hybridisation (FISH) assay Urovysion© (Vysis, Inc., Downers Grove, Illinois) and NMP22-BladderChek© (Matritech Inc., Newton, MA, USA) for detection of TCC of the bladder from voided urinary specimen and comparison to standard cytology. MATERIAL & METHODS: Voided urine samples from 90 patients were obtained for urine cytology, FISH analyzes and NMP22-BladderChek©. The collective included 60 patients with suspected bladder cancer or a history of bladder cancer that were in regular follow-up. In case of suspicious findings, patients underwent TURB or bladder biopsy. 30 healthy patients served as controls. RESULTS: Results of sensitivities are shown in Table 1. For low grade TCC (G1), FISH had a three times higher sensitivity than either NMP22-BladderChek© or Cytology. For high grade TCC (G3), FISH and cytology had higher sensitivities than NMP22-BladderChek©. Specificity in the control group for FISH, NMP22-BladderChek© and cytology was 100%, 90% and 88%, respectively. All tests had lower specificity in patients with a history of bladder cancer (Specificity: FISH=45%; NMP22=70%; Cytology=75%). In 14 urinary samples (15,5%), FISH signals could not be sufficiently counted due to inadequate cell numbers in the probes. The same problem applied to 9 (10%) urinary samples for cytology. One NMP22-BladderChek© (1.1%) was classified as invalid. CONCLUSIONS: In this series, FISH was the best method to detect bladder cancer in voided urine specimen. In particular, FISH was superior for detection of low grade TCC. Still, about 50% of the low grade tumours would be missed without cystoscopy. The specificity of FISH in patients with a history of bladder cancer seems to be too low. However, false positive FISH might reflect sub clinical recurrence and therefore positive FISH might be of prognostic value. Further follow-up of those patients will help to interpret these results.
Please log-in or register in order to submit comments. Powered by AkoComment! |
||
| < Prev | Next > |
|---|
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2008 UroToday ® All Rights Reserved |








